Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | February 22, 2023 09:06am

Gainers

  • Windtree Therapeutics (NASDAQ:WINT) stock increased by 28.8% to $0.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.5 million.
  • Sorrento Therapeutics (NASDAQ:SRNE) shares moved upwards by 24.8% to $0.48. The market value of their outstanding shares is at $263.5 million.
  • MediciNova (NASDAQ:MNOV) stock increased by 16.52% to $2.68. The market value of their outstanding shares is at $131.4 million.
  • Cognition Therapeutics (NASDAQ:CGTX) shares moved upwards by 16.2% to $1.9. The company's market cap stands at $55.0 million.
  • Immix Biopharma (NASDAQ:IMMX) stock rose 15.45% to $2.39. The company's market cap stands at $33.2 million.
  • Spruce Biosciences (NASDAQ:SPRB) shares increased by 12.5% to $2.7. The company's market cap stands at $63.6 million.

Losers

  • Monopar Therapeutics (NASDAQ:MNPR) stock decreased by 17.0% to $2.78 during Wednesday's pre-market session. The company's market cap stands at $35.9 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares decreased by 15.97% to $1.0. The market value of their outstanding shares is at $4.8 million.
  • Chemomab Therapeutics (NASDAQ:CMMB) shares decreased by 14.85% to $1.95. The market value of their outstanding shares is at $22.4 million.
  • Aclarion (NASDAQ:ACON) shares fell 11.71% to $0.68. The market value of their outstanding shares is at $5.3 million.
  • eFFECTOR Therapeutics (NASDAQ:EFTR) stock declined by 10.01% to $0.45. The company's market cap stands at $18.9 million.
  • Charles River (NYSE:CRL) shares fell 10.0% to $219.25. The market value of their outstanding shares is at $11.1 billion. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON CGTX CMMB CRL EFTR IMMX MNOV MNPR QNRX SPRB SRNE WINT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist